CorMedix Inc.CRMDNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank97
5Y CAGR+63.5%
Year-over-Year Change
Year-over-year free cash flow growth rate
5Y CAGR
+63.5%/yr
Long-term compound
Percentile
P97
Near historical high
vs 5Y Ago
11.7x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 211.09% |
| Q3 2025 | 1.28% |
| Q2 2025 | 51.92% |
| Q1 2025 | 450.73% |
| Q4 2024 | 58.82% |
| Q3 2024 | 2.95% |
| Q2 2024 | 18.98% |
| Q1 2024 | -57.33% |
| Q4 2023 | -26.80% |
| Q3 2023 | -1.50% |
| Q2 2023 | 17.58% |
| Q1 2023 | -65.65% |
| Q4 2022 | -3.49% |
| Q3 2022 | -10.96% |
| Q2 2022 | 18.92% |
| Q1 2022 | -3.86% |
| Q4 2021 | -3.45% |
| Q3 2021 | -102.81% |
| Q2 2021 | 53.80% |
| Q1 2021 | -11.54% |
| Q4 2020 | 18.05% |
| Q3 2020 | -867.09% |
| Q2 2020 | 90.49% |
| Q1 2020 | -104.84% |
| Q4 2019 | 1.88% |
| Q3 2019 | -2565.82% |
| Q2 2019 | 102.18% |
| Q1 2019 | -2.59% |
| Q4 2018 | -40.59% |
| Q3 2018 | -18.13% |
| Q2 2018 | 38.87% |
| Q1 2018 | 4.19% |
| Q4 2017 | -8.50% |
| Q3 2017 | 12.00% |
| Q2 2017 | -14.68% |
| Q1 2017 | -3.98% |
| Q4 2016 | 1.53% |
| Q3 2016 | -75.15% |
| Q2 2016 | 30.84% |
| Q1 2016 | -49.88% |